Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of March 17, 2025, while removing a previous status indicating that the position was active but not recruiting, along with a date of December 5, 2024.SummaryDifference2%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check32 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check47 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check68 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.